1 Min Read
March 19 (Reuters) - Vistagen Therapeutics Inc:
* VISTAGEN THERAPEUTICS RECEIVES A NOTICE OF ALLOWANCE FOR ANOTHER KEY U.S. PATENT COVERING ORAL FORMULATIONS OF AV-101 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.